Is there a new role for induction chemotherapy in the treatment of head and neck cancer?
- PMID: 15547172
- DOI: 10.1093/jnci/djh339
Is there a new role for induction chemotherapy in the treatment of head and neck cancer?
Comment on
-
Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up.J Natl Cancer Inst. 2004 Nov 17;96(22):1714-7. doi: 10.1093/jnci/djh306. J Natl Cancer Inst. 2004. PMID: 15547184 Clinical Trial.
Similar articles
-
Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up.J Natl Cancer Inst. 2004 Nov 17;96(22):1714-7. doi: 10.1093/jnci/djh306. J Natl Cancer Inst. 2004. PMID: 15547184 Clinical Trial.
-
Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?Cancer Lett. 2007 Oct 28;256(2):166-77. doi: 10.1016/j.canlet.2007.06.015. Epub 2007 Jul 27. Cancer Lett. 2007. PMID: 17673364 Review.
-
Emerging drugs for head and neck cancer.Expert Opin Emerg Drugs. 2004 May;9(1):91-104. doi: 10.1517/eoed.9.1.91.32953. Expert Opin Emerg Drugs. 2004. PMID: 15155138 Review.
-
Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.Cancer Chemother Pharmacol. 2008 Dec;63(1):9-17. doi: 10.1007/s00280-008-0702-1. Epub 2008 Mar 15. Cancer Chemother Pharmacol. 2008. PMID: 18343925 Clinical Trial.
-
Concurrent chemotherapy and radiotherapy for head and neck cancer.Expert Rev Anticancer Ther. 2009 Mar;9(3):293-302. doi: 10.1586/14737140.9.3.293. Expert Rev Anticancer Ther. 2009. PMID: 19275508 Review.
Cited by
-
A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma.Clin Cancer Res. 2018 Jun 15;24(12):2740-2748. doi: 10.1158/1078-0432.CCR-17-3796. Epub 2018 Mar 13. Clin Cancer Res. 2018. PMID: 29535125 Free PMC article. Clinical Trial.
-
Neoadjuvant chemotherapy: does it have benefits for the surgeon in the treatment of advanced squamous cell cancer of the oral cavity?Pathol Oncol Res. 2010 Jun;16(2):207-12. doi: 10.1007/s12253-009-9208-3. Epub 2009 Sep 12. Pathol Oncol Res. 2010. PMID: 19757193 Clinical Trial.
-
Evaluation of overall tumor cellularity after neoadjuvant chemotherapy in patient with locally advanced hypopharyngeal cancer.Eur Arch Otorhinolaryngol. 2012 Nov;269(11):2391-9. doi: 10.1007/s00405-011-1915-1. Epub 2012 Jan 10. Eur Arch Otorhinolaryngol. 2012. PMID: 22231797
-
Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216).Head Neck. 2010 Feb;32(2):221-8. doi: 10.1002/hed.21179. Head Neck. 2010. PMID: 19557750 Free PMC article. Clinical Trial.
-
Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro.Clin Cancer Res. 2011 Apr 1;17(7):1815-27. doi: 10.1158/1078-0432.CCR-10-2120. Epub 2011 Feb 24. Clin Cancer Res. 2011. PMID: 21350000 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical